title: Inhibition of sphingolipid metabolism enhances resveratrol chemotherapy in human gastric cancer cells.
abstract: Resveratrol, a chemopreventive agent, is rapidly metabolized in the intestine and liver via glucuronidation. Thus, the pharmacokinetics of resveratrol limits its efficacy. To improve efficacy, the activity of resveratrol was investigated in the context of sphingolipid metabolism in human gastric cancer cells. Diverse sphingolipid metabolites, including dihydroceramides (DHCer), were tested for their ability to induce resveratrol cytotoxicity. Exposure to resveratrol (100 μM) for 24 hr induced cell death and cell cycle arrest in gastric cancer cells. Exposure to the combination of resveratrol and dimethylsphingosine (DMS) increased cytotoxicity, demonstrating that sphingolipid metabolites intensify resveratrol activity. Specifically, DHCer accumulated in a resveratrol concentration-dependent manner in SNU-1 and HT-29 cells, but not in SNU-668 cells. LC-MS/MS analysis showed that specific DHCer species containing C24:0, C16:0, C24:1, and C22:0 fatty acids chain were increased by up to 30-fold by resveratrol, indicating that resveratrol may partially inhibit DHCer desaturase. Indeed, resveratrol mildly inhibited DHCer desaturase activity compared to the specific inhibitor GT-11 or to retinamide (4-HPR); however, in SNU-1 cells resveratrol alone exhibited a typical cell cycle arrest pattern, which GT-11 did not alter, indicating that inhibition of DHCer desaturase is not essential to the cytotoxicity induced by the combination of resveratrol and sphingolipid metabolites. Resveratrol-induced p53 expression strongly correlated with the enhancement of cytotoxicity observed upon combination of resveratrol with DMS or 4-HPR. Taken together, these results show that DHCer accumulation is a novel lipid biomarker of resveratrol-induced cytotoxicity in human gastric cancer cells.
authors.affiliation: College of Pharmacy and MRC, Chungbuk National University, Chongju 361-763, Republic of Korea.
authors.forename: Kyong-Oh
authors.initials: KO
authors.lastname: Shin
authors.forename: Nam-Young
authors.initials: NY
authors.lastname: Park
authors.forename: Cho-Hee
authors.initials: CH
authors.lastname: Seo
authors.forename: Seon-Pyo
authors.initials: SP
authors.lastname: Hong
authors.forename: Ki-Wan
authors.initials: KW
authors.lastname: Oh
authors.forename: Jin-Tae
authors.initials: JT
authors.lastname: Hong
authors.forename: Sang-Kil
authors.initials: SK
authors.lastname: Han
authors.forename: Yong-Moon
authors.initials: YM
authors.lastname: Lee
keywords: 4-HPR; Dihydroceramide desaturase; Gastric cancer; Resveratrol; Sphingosine kinase